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Objectives: Traumatic thoracic aortic injury (TTAI) is associated with high mortality rates. Data supporting thoracic
endovascular aortic repair (TEVAR) to reduce mortality and morbidity for TTAI is limited to small series and
meta-analyses. In this study, we evaluated the trends and outcomes of open surgery and TEVAR for TTAI in New York
State.
Methods: All cases of TTAI in New York State between 2000 and 2007 were extracted from the New York Statewide
Planning and Research Cooperative System (SPARCS) database. A diagnosis by International Classification of Diseases,
9th Revision coding of TTAI was required for inclusion.
Results:We identified 328 patients with TTAI who underwent surgical repair in New York State between 2000 and 2007;
mean age of the cohort was 39.3 years  18 years; 80% were male. Open repair of TTAI was performed in 79.6% and
20.4% underwent TEVAR. Open repair was performed for all cases of TTAI until the introduction of TEVAR in 2005;
TEVAR exceeded the use of open repair for TTAI in 2006 and 2007. Additional major injuries were present in 71.7% in
the open repair group vs 91.0% of the TEVAR group (P  .001). The overall in-hospital mortality rate for the 8-year
period was significantly increased after open repair of TTAI compared with TEVAR: 17% vs 6%, (odds ratio [OR] 3.19,
95% confidence interval [CI], 1.11-9.23; P  .024). After controlling for the significant covariates, TEVAR indepen-
dently reduced the risk of death following surgical intervention for TTAI compared with the open procedure (OR 3.8,
95% CI, 1.28-10.99; P  .010). Respiratory complications were the most common postoperative morbidity, and were
significantly increased after open repair: 38% vs 24% (OR 1.95; 95% CI, 1.05-3.60; P  .032). There were no significant
differences in cardiac complications, acute renal failure (ARF), paraplegia, or stroke. Endoleak and distal embolization
each occurred in 9% of patients after TEVAR.
Conclusions: There has been a shift toward endovascular management of patients with TTAI. This change in surgical
strategy has been associated with less postoperative mortality and fewer pulmonary complications in patients suffering
from TTAI. TEVAR is associated with significant device-related complications. ( J Vasc Surg 2010;51:565-71.)Traumatic thoracic aortic injury (TTAI) is the second
most common cause of death in trauma patients, account-
ing for about 8000 deaths per year in the United States.1,2
TTAI is typically caused by blunt trauma and occurs in
approximately 0.3% of all trauma admissions and in 1.2% of
all motor-vehicle accidents.3,4 Up to 90% of patients with
TTAI will die at the scene of an accident.5,6 A considerable
number of patients expires after admission as well, although
the in-hospital mortality of patients with TTAI has de-
creased significantly over time.7,8 Reasons for improved
outcome of TTAI are increased use of passengers restraints,
development of trauma centers, institution of -blockers,
improvement in mechanical circulatory support, and intro-
duction of novel surgical procedures and technologies,
such as endovascular repair.4,7
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doi:10.1016/j.jvs.2009.10.046Open surgical repair with thoracotomy and interposi-
tion of an aortic graft has been the traditional method of
treating TTAI. In-hospital mortality of open surgery for
TTAI is about 20%.9,10 In addition, there is significant
morbidity such as paraplegia in up to 15% of patients.11
Recently, thoracic endovascular aortic repair (TEVAR) has
been established as a safe and feasible technique for treat-
ment of thoracic aortic pathologies.12,13 TEVAR allows
quick exclusion of the aortic lesion and is less invasive than
open surgery, which is particularly desirable in patients with
TTAI and multiple associated injuries. TEVAR appears to
lower mortality and morbidity rates in patients with
TTAI.9-11 Nevertheless, TEVAR is still associated with a
number of considerable complications such as endoleak,
graft fracture and graft migration, necessitating life-long
surveillance.
Due to the low incidence of TTAI, the current litera-
ture consists mainly of case series with limited numbers. For
the present study, we evaluated all cases of TTAI in New
York State from 2000 to 2007 treated with open surgery
and TEVAR, and the impact of endovascular repair on the
in-hospital outcomes of TTAI was investigated.
METHODS
Discharge data for patients who were admitted with
TTAI between 2000 and 2007 were extracted from the
New York State Statewide Planning and Research Cooper-
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the 1970s, this system has been collecting hospital dis-
charge data for more than 30 years (http://www.health.
state.ny.us/statistics/sparcs/index.htm). The New York
Department of Health maintains the database, which in-
cludes 225 hospitals in the State of New York (the third
largest state by population in the United States). The
database contains individual demographic and clinical in-
formation of every patient discharged from an acute-care
nonfederal hospital, which must be submitted by the hos-
pital within 60 days after the month of the patient’s dis-
charge. Since the introduction of SPARCS, this dataset has
been used to support many research projects.
We extracted all patients with TTAI from the SPARCS
database on the base of diagnosis codes. All patients with
the diagnosis code 901.0 (injury to the thoracic aorta) were
included. Those with the ICD-9 codes pertaining to rup-
tured and nonruptured thoracic aneurysms (441.1, 441.2)
and aortic dissection (441.0) were excluded. The type of
surgical repair performed was identified with ICD-9 proce-
dure codes. Patients treated with open surgery had the
ICD-9 procedure codes 38.45 (resection of thoracic aorta
with replacement) or 38.55 (ligation of thoracic aorta).
Patients who received TEVAR were identified with ICD-9
procedure code 39.73 (endovascular implantation of graft
in the thoracic aorta).
The following baseline characteristics were extracted
for all patients in open repair and TEVAR groups: age,
gender, year of diagnosis, comorbid diseases, including
diabetes mellitus (DM), hypertension, chronic obstructive
pulmonary disease (COPD), peripheral vascular disease
(PVD), chronic renal insufficiency (CRI), cerebrovascular
disease (CVD), hyperlipidemia, and associated injuries in-
cluding cerebral injury (intracranial hemorrhage, subarach-
noid hemorrhage, subdural hemorrhage, extradural hem-
orrhage), lung injury, cardiac injury, liver injury, spleen
injury, and pelvic fracture. Additionally, the admission type
(emergency, urgent, or elective) was determined for all
patients. Data regarding the year of each surgical procedure
for TTAI were used to demonstrate the trend in operative
management.
The following outcomes were compared between pa-
tients treated with open surgery and TEVAR: in-hospital
mortality, in-hospital complications, including cardiac com-
plications, pulmonary complications, paraplegia, stroke,
acute renal failure (ARF), bleeding, infection, mesenteric
ischemia, urinary complications, distal embolization, and
endoleak. The mean length of stay and the disposition after
discharge (home, acute care, nursing home, home services,
rehabilitation) will be compared between both treatment
groups.
Statistical analysis. All data were analyzed with SAS
system software (SAS Institute, Cary, NC). The Cochran-
Armitage trend test was used to investigate the trend in
aortic interventions. Categorical variables were compared
between patients that were treated with open surgery and
TEVAR, using univariate analysis and the 2 test. Fisher’s
exact test was used if the expected count was less than 5.Continuous variables with a normal distribution were com-
pared between the open surgery group and the TEVAR
group using Student’s t test. Outcome results are expressed
as both P values and 95% confidence intervals (95% confi-
dence interval [CI]). P values .050 were considered sig-
nificant in our univariate analysis, and significant variables
were evaluated using simple regression analysis.
Variables obtained using simple logistic regression
analysis, with a level of significance .25, were included in
a multiple logistic regression analysis. This multivariable
regression model examined the dichotomous outcome
(dead/alive) and associated risk factors. Only variables with
P values .05 were included in the final model. Indepen-
dent variables that were significantly correlated with both
the outcome: death and the predictor of interest: type of
surgery (TEVAR vs open) were stratified and examined
individually. Clinical reasoning determined the choice for
inclusion between independent variables that significantly
correlated with each other.
RESULTS
Incidence of TTAI and trends in operative ma-
nagement. In total, 659patientswho sustainedTTAI inNew
York State between 2000 and 2007 were identified. The
annual incidence of TTAI increased slightly over the study
period; the mean annual incidence during this period was
82.4 patients (Fig 1).
Overall, 49.8% (n  328) underwent surgical repair,
and this subset of patients was the object of our analysis.
The balance of patients underwent conservative therapy or
expired before surgical intervention could be performed.
The majority of patients received open surgical repair (n 
261, 79.6%); remaining patients underwent TEVAR (n 
67, 20.4%). Four additional patients underwent both an
endovascular and an open surgical procedure; these cases
were presumed to be endovascular cases, which were con-
verted to open procedures and were excluded from further
analysis. Open repair was performed for all cases of TTAI
until 2005, when endovascular repair was introduced in
New York State (Fig 2). TEVAR rapidly became the pre-
Fig 1. Annual rate of admitted patients with TTAI in New York
State between 2000 and 2007.ferred technique for TTAI by 2006. With the advent of
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that underwent an aortic intervention significantly in-
creased (Fig 3, Cochran-Armitage trend test: P  .043).
Baseline characteristics. Mean patient age of the
TEVAR cohort was 41.6 years and 38.7 years in the open
cohort; 79.6% were male. There were no significant differ-
ences in the mean age, gender, or rates of preadmission
comorbidities between the open repair and TEVAR groups
(Table I). Additional injuries to a major organ system were
identified in 76% (n 248) of TTAIs. Overall, 91.0% (n
61) of patients in the TEVAR group vs 71.7% (n 187) of
the open repair group had any of these injuries (P .001).
Admitted patients treated with TEVAR suffered more fre-
quently from cerebral injury (22.4% vs 8.8%, P  .002),
lung injury (79.1% vs 53.6%, P  .001), spleen injury
(40.3% vs 16.1%, P  .001), and pelvic fracture (38.8% vs
23.4%, P .011) compared with patients treated with open
repair (Table I). Admissions in the open repair of TTAI
were more frequently coded as emergent than admissions
in the TEVAR group; 90.8% (n 237) vs 80.6% (n 54),
Fig 2. Aortic interventions for TTAI in New York State between
2000 and 2007.
Fig 3. Trend in proportion of patients with TTAI receiving aortic
intervention. With the advent of TEVAR in 2005, the proportion
of admitted TTAI patients that underwent an aortic intervention
significantly increased (Cochran-Armitage trend test: P  .043).P  .019 (Table I).Patient outcomes. Overall, the in-hospital mortality
rate was 14.6% (n  48) among patients that underwent
intervention for TTAI, compared with 24.8% (n  81) in
the TTAI patients that did not receive intervention (P 
.0011). In our univariate analysis, an increased in-hospital
mortality rate for the eight year period was significantly
associated with open repair of TTAI compared with
TEVAR: 16.9% (n 44) vs 6.0% (n 4), odds ratio [OR]
3.19 (95% CI, 1.11-9.23; P  .024).
Of all deaths, 90% (n  43) occurred in patient admit-
ted with an additional injury to a major organ system and
10% (n  5) in patients without additional injuries. In our
analysis stratified by the presence of an additional injury,
controlling for this likely confounder, 91% (n  39) of the
deaths occurred in the open group and 9% (n  4) in the
TEVAR group. The in-hospital mortality rate for the co-
hort with additional major injuries was 20.9% (39/187) for
patients treated with open repair vs 6.6% (4/61) for pa-
tients treated with TEVAR (P .010). We did not identify
a significant difference in the rates of death comparing open
surgery with TEVAR in the population admitted without
additional injury.
Emergent admission designation within the SPARCS
database was significantly correlated with the presence of an
additional injury to a major organ system and was, there-
fore, not included in our regression models. Age, gender,
Table I. Admission characteristics
Open repair
(n  261)
TEVAR
(n  67)
P value
N or mean
(% or  SD)
N or mean
(% or  SD)
Age (y) 38.7 (18.0) 41.6 (17.9) .242
Male gender 202 (79.8) 59 (78.7) .825
Patient history
DM 10 (3.8) 3 (4.5) .809
Hypertension 39 (14.8) 11 (16.4) .764
COPD 12 (4.6) 6 (9.0) .162
CAD 4 (1.5) 2 (3.0) .429
PVD 2 (0.8) 0 0 .472
CRI 4 (1.5) 0 0 .308
CVD 4 (1.5) 2 (3.0) .429
Hyperlipidemia 4 (1.5) 0 0 .308
Associated injuries
Cerebral injurya 23 (8.8) 15 (22.4) .002
Lung injurya 140 (53.6) 53 (79.1) .001
Cardiac injury 9 (3.5) 2 (3.0) .298
Liver injury 59 (22.6) 9 (13.4) .098
Spleen injurya 42 (16.1) 27 (40.3) .001
Pelvic fracturea 61 (23.4) 26 (38.8) .011
Any of abovea 187 (71.7) 61 (91.0) .001
Admission type
Emergenta 237 (90.8) 54 (80.6) .019
Urgent 21 (8.1) 10 (14.9) .086
Elective 3 (1.2) 3 (4.5) .070
TEVAR,Thoracic endovascular aortic repair;DM, diabetes mellitus;COPD,
chronic obstructive pulmonary disease; CAD, coronary artery disease; PVD,
peripheral vascular disease; CRI, chronic renal insufficiency; CVD, cerebro-
vascular disease; SD, standard deviation.
aSignificant difference.and comorbidities were not significant predictors of death
JOURNAL OF VASCULAR SURGERY
March 2010568 Jonker et alin regression analysis. Type of surgery, however, was a
significant predictor of death after controlling for the pres-
ence of additional injury. The patient cohort admitted with
additional injuries was 3.8 times (95% CI, 1.28-10.99) as
likely to die if they underwent an open procedure compared
with TEVAR.
Respiratory complications were the most common
postoperative morbidity, and were significantly associated
with open repair of TTAI compared with TEVAR: 37.9%
(n 99) vs 23.9% (n 16), OR 1.95 (95% CI, 1.05-3.60,
P  .032). Rates of postoperative bleeding were similar
after both open repair and TEVAR: 24.5% (n  64) vs
17.9% (n  12), P  .253. There were no significant
differences in cardiac complications, acute renal failure
(ARF), stroke, or paraplegia between both groups (Table
II). Endoleak and distal embolization occurred each in
9.0% (n  6) after TEVAR (P  .0001).
Mean hospital length of stay was slightly increased after
open repair compared with TEVAR, 22.9 days vs 19.3 days
(P  .085). Most patients were discharged home after
repair of TTAI: 29.1% (n  76) of the open repair group
and 32.8% (n 22) of the TEVAR group (not significant).
Patients who received open repair went more frequently to
acute care facilities after discharge, while patients treated
with TEVAR were more often discharged to a rehabilita-
tion center or a nursing home (Table III).
DISCUSSION
About 80 patients with TTAI are admitted to hospitals
in New York State every year. Recently, there has been a
major shift away from open surgery to endovascular man-
agement of these patients. This trend has been associated
with decreased mortality and postoperative pulmonary
complications.
The diagnosis and management of TTAI have under-
gone several major changes in the last decades. The rapid
Table II. In-hospital outcomes of open repair and TEVA
Open repair
(n  261)
N (%) N
Mortalitya 44 (16.9) 4
Complications
Cardiac 14 (5.4) 2
Stroke 6 (2.3) 2
Pulmonarya 99 (37.9) 16
Paraplegia 2 (0.8) 0
ARF 5 (1.9) 2
Bleeding 64 (24.5) 12
Infection 7 (2.7) 2
Mesenteric 2 (0.8) 0
Urinary 4 (1.5) 0
Distal embolizationa 0 (0) 6
Endoleaka 0 (0) 6
TEVAR, Thoracic endovascular aortic repair; TTAI, traumatic thoracic aor
aSignificant difference.advancement of computed tomography availability, with itsless invasive nature and its sensitivity and specificity, has
resulted in its almost-complete replacement of aortography
for the diagnosis of TTAI.8 There have also been several
developments in treatment strategies. The majority of pa-
tients with TTAI still die at the scene of the accident, but
for those who live to be admitted to the hospital, there has
been a shift from early to delayed definitive repair.8 The
optimal timing for definitive repair of TTAI is not known.
Traditionally, early repair was preferred in all patients.
Generally, patients with TTAI are categorized as “unsta-
ble”, in whom survival is extremely low, and “stable”.14,15
Clearly, immediate intervention is indicated in unstable
patients, as delay to evaluation and the operating room are
risk factors for mortality.16 The timing of surgical repair has
changed in stable patients with TTAI. In selected cases with
major associated injuries, delayed definitive repair has been
associated with reduced mortality.17-19 Antihypertensive
therapy with -blockers can eliminate in-hospital free rup-
ture in these patients, resulting in a further decrease of
Table III. Discharge characteristics after open repair and
TEVAR for TTAI
Open
(n  261)
TEVAR
(n  67)
P value
N or mean
(% or SD)
N or mean
(% or SD)
LOS 22.9 (20) 19.3 (14) .085
Discharge destination
Home 76 (29.1) 22 (32.8) .553
Acute care facilitya 73 (28.0) 6 (9.0) .001
Nursing home 10 (3.8) 7 (10.5) .029
Home services 22 (8.4) 10 (14.9) .110
Rehabilitation centera 28 (10.7) 16 (23.9) .005
TEVAR, Thoracic endovascular aortic repair; TTAI, traumatic thoracic
aortic injury; LOS, length of stay; SD, standard deviation.
aSignificant difference.
TTAI
VAR
 67)
OR 95% CI P value(%)
(6.0) 3.19 1.11-9.23 .024
(2.9) 1.84 0.41-8.31 .420
(2.9) 0.76 0.15-3.88 .745
(23.9) 1.95 1.05-3.60 .032
(0) 1.01 0.99-1.02 .472
(3.0) 0.63 0.12-3.35 .589
(17.9) 1.49 0.75-2.95 .253
(3.0) 0.90 0.18-4.41 .892
(0) 1.01 0.99-1.02 .472
(0) 1.02 1.00-1.03 .308
(9.0) — — .0001
(9.0) — — .0001
ry; OR, odds ratio; CI, confidence interval; ARF, acute renal failure.R for
TE
(n
tic injuin-hospital mortality.1,15,20
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racic aortic pathologies,12,13 has further changed the man-
agement of TTAI. TEVAR allows prompt exclusion of the
aortic injury and does not require thoracotomy or aortic
clamping, which are undesirable in unstable patients with
multiple associated injuries. Blood loss is reduced and
systemic heparinization and perioperative lung ventilation
are less often necessary. In many centers, endovascular
treatment has become the procedure of choice for TTAI,
even in young patients.8,9 We demonstrated a similar phe-
nomenon in New York State. TEVAR appeared to be
preferred in particular for patients with multiple associated
injuries (Table I). Furthermore, the proportion of admitted
TTAI patients that received an aortic intervention appeared
to increase since 2005 when TEVAR became widely avail-
able in New York State (Fig 3).
In our evaluation, the in-hospital mortality after
TEVAR was 6% vs 17% after open surgery for TTAI, which
was a statistically significant difference. After controlling for
the significant covariates, TEVAR independently reduces
the risk of death following surgical intervention for TTAI
compared with the open procedure. Our findings are sim-
ilar to a recent meta-analysis by Tang et al, which demon-
strated a 30-day mortality of 7.6% and 15.2% after TEVAR
and open surgery, respectively.21 Other meta-analyses and
large series have shown results comparable to the in-hospital
mortality in New York State.9-11,22-24 The only large evalu-
ation that did not support the superiority of TEVAR for
TTAI, was the study of Arthurs et al, that found a 30-day
mortality of 19% and 18% after open repair and TEVAR,
respectively.3 However, in their nation-wide analysis of
patients with blunt TTAI, they evaluated the results of
open and endovascular repairs between 2000 and 2005.
Therefore, the endovascular devices utilized in their evalu-
ation represent the initial experience with custom-made
devices or off-label use of aortic cuffs.3 This may explain the
increased mortality after TEVAR in their analysis compared
with our results and the literature.
In addition, pulmonary complications were signifi-
cantly reduced with TEVAR. An increased incidence of
pneumonia after open repair of TTAI compared with
TEVAR has been described previously;11 particularly in
patients with associated major extra-thoracic injuries.9
Paraplegia is probably the most devastating complication of
thoracic aortic interventions, and its incidence is increased
after open surgery. Paraplegia occurs in approximately 5.6%
to 7% of patients after open surgery, compared with less
than 1% after TEVAR.21,23,24 Demetriades et al demon-
strated that procedure-related paraplegia after open surgery
for TTAI has significantly decreased from 8.7% to 2.9%
during the last decade.8 This improved outcome could be
the result of better resuscitation and a more controlled
environment during delayed repair of TTAI.8,19 Further-
more, shorter aortic cross-clamp time and adjuncts for
distal aortic perfusion during open TTAI repair, might have
contributed to the observed decrease in the incidence of
paraplegia,25,26 although some question the benefits of
these such bypass techniques in this patient group.9,16,27 Inour evaluation, permanent paraplegia occurred in less than
1% after open repair and not at all after TEVAR. The
reported rate of postoperative stroke, another neurologic
complication, is decreased after TEVAR compared with
open surgery for TTAI as well.21 Our data did not support
this finding.
Although the initial results of endovascular treatment
for TTAI are encouraging, there continues to be concern
about device-related complications. Endoleak and distal
embolization were each identified in 9% in the patients
undergoing TEVAR. Since TTAI typically occurs at the
aortic isthmus, coverage of the left subclavian artery is
required in up to 66% of patients for adequate proximal
seal.11,28 Coverage of the left subclavian artery may lead to
brachial ischemia, and without revascularization, it is a risk
factor for paraplegia and stroke.29,30 Furthermore, throm-
bosis of the subclavian and brachial arteries, iliac rupture,
stent graft migration, fracture, and collapse have all been
reported.24 Unfortunately, limitations in coding prevent us
from evaluating these specific complications in the
SPARCS data set.
The experience with TEVAR for TTAI is still very
limited and long-term outcomes of TEVAR for TTAI are
unknown to date. Therefore, life-long surveillance is indi-
cated after TEVAR. Computed tomography with angiog-
raphy is the preferred imaging method for surveillance after
endovascular treatment, but this would result in a consid-
erable radiation exposure among young trauma patients
over time. The mean age of patients that received TEVAR
for TTAI was 39 years in our evaluation, which is consid-
erably younger than patients undergoing endovascular
treatment for aortic aneurysms.
For the present study, we investigated the outcomes of
a large cohort of patients that received surgical repair for
TTAI. Still, there are several potential limitations of our
analysis. First, patients in the present study were not ran-
domized by repair type. Since this was an observational
study, the open repair and TEVAR groups were not com-
pletely identical. TEVAR patients had more additional
major injuries, while admissions in the open repair of TTAI
were more frequently coded as emergent (Table II). These
factors may affect the outcomes, therefore, multivariable
regression analysis was performed, which confirmed that
TEVAR was independently associated with improved in-
hospital mortality.
Management of complications such as endoleak after
TEVAR could not be extracted from SPARCS, and long-
term patient outcomes were not available as well. Another
limitation is that the ICD-9 procedure code for endovas-
cular repair was initiated in 2005. Although the utilization
of thoracic stent grafts for the treatment of thoracic aortic
disease in the United States was approved by the FDA in
2005 as well, some TTAI patients in New York State may
have received TEVAR before 2005. It is difficult to deter-
mine how these TEVAR patients were coded. If some of
these TEVAR patients were included in the open repair
group, the in-hospital mortality of the open repair group
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the in-hospital mortality in our analysis.
Furthermore, although the data were prospectively col-
lected in the SPARCS database, there may be a variation in
reporting precision and coding errors. Data extracted from
administrative databases like SPARCS usually provide reli-
able information, but comorbid diseases may be underre-
ported.31,32 The influence of this potentially confounding
factor is thought to be small, since there were no substantial
differences in comorbidity between the open surgery group
and the TEVAR group and the prevalence of pre-existing
comorbidities is thought to be relatively low in trauma
patients. Moreover, our findings regarding the mortality
rates in both repair groups are supported by previous
reports.9-11,21-24
CONCLUSION
Management of TTAI has undergone major changes
recently. In many centers in New York State, endovascular
treatment has become the procedure of choice, especially if
additional injuries are present. This trend is associated with
decreased in-hospital mortality and postoperative pulmo-
nary complications in patients suffering from TTAI. How-
ever, TEVAR is also associated with significant device-
related complications.
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